{"article_title": "Under Obamacare, Risks Grow for High-Margin Drug Stocks", "article_keywords": ["obamacare", "drug", "risks", "stocks", "highmargin", "grow"], "article_url": "http://www.forbes.com/sites/hilarykramer/2014/01/16/under-obamacare-risks-grow-for-high-margin-drug-stocks/", "article_text": "", "article_metadata": {"description": "After seeing my favorite \u201c2014 top pick\u201d biotech stock rewarded last week with a 500% rally, I\u2019m scouring the market looking for the next dramatic pipeline catalyst. But despite plenty of candidates, a less forgiving reimbursement environment may mean the days of 90% margins on life-saving drugs may be winding [...]", "author": "Hilary Kramer", "og": {"site_name": "Forbes", "description": "After seeing my favorite \u201c2014 top pick\u201d biotech stock rewarded last week with a 500% rally, I\u2019m scouring the market looking for the next dramatic pipeline catalyst. But despite plenty of candidates, a less forgiving reimbursement environment may mean the days of 90% margins on life-saving drugs may be winding [...]", "title": "Under Obamacare, Risks Grow for High-Margin Drug Stocks", "url": "http://www.forbes.com/sites/hilarykramer/2014/01/16/under-obamacare-risks-grow-for-high-margin-drug-stocks/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2014-01-16T10:45:34-05:00", "type": "article"}, "twitter": {"site": "@forbes", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "description": "After seeing my favorite \u201c2014 top pick\u201d biotech stock rewarded last week with a 500% rally, I\u2019m scouring the market looking for the next dramatic pipeline catalyst. But despite plenty of candidates, a less forgiving reimbursement environment may mean the days of 90% margins on life-saving drugs may be winding [...]", "card": "summary_large_image", "title": "Under Obamacare, Risks Grow for High-Margin Drug Stocks"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2014-01-16", "published": "2014-01-16", "id": "blogAndPostId/blog/post/1270-707"}, "news_keywords": "Business", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "_id": "\"57477af36914bd0286fce830\"", "article_summary": ""}